As we count down to the annual ADA gathering our attention isn’t so much what we will see in San Francisco but what we won’t see. Anticipating what we will see is pretty easy as there will be new toys for that ever-growing toy chest. There will be reams of data on new drugs for the medicine cabinet and there will be a plethora of way cool whiz bangs apps. Yet what we won’t see or likely hear is anything about one of the biggest if not the biggest problems in diabetes; patient access.
Recently we . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.